Cohen Children's Medical Center
New Hyde Park, New York, 11040, United States
Location status: Recruiting
NCT Number: NCT06986863
The purpose of this research study is to compare the Always Uniquely Me (AUM) mobile application to regular medical care. The investigators want to know if AUM is helpful at decreasing use of restraints and improving experience in the emergency department (ED) for people with intellectual and developmental disabilities (PWIDD). The investigators will also be looking at how certain characteristics of the PWIDD participants may affect those outcomes.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
New Hyde Park, New York, 11040, United States
Location status: Recruiting
PWIDD have high rates of ED use and poor quality of experience in EDs compared to the general population. Among a multistate cohort of adults with IDD, the risk of emergency department visits for adults with IDD was more than twice that for other adults, particularly for conditions that can be safely treated in the community (e.g., urinary tract and respiratory infections), and psychiatric conditions.1 PWIDD were more likely than those without IDD to visit the ED in a population based cohort in Ontario, Canada. For both groups, receiving greater continuity of primary care was associated with less ED use, but this relationship was more marked for adults with IDD. Another national study also found that compared to children with IDD with no emergency room visits, those with 3 or more emergency room visits were less likely to report access to a source of outpatient healthcare.
PWIDD have poor experiences in EDs. A large survey of PWIDD recently admitted to a hospital who were recruited from disability service organizations found that 12% did not always get the right medication; 22% didn't get their medication on time or only sometimes; 18% didn't get enough to drink; 13% didn't get enough to eat; 39% could not get to the toilet when they needed to, while 7% could do so only sometimes; and 11% reported not getting help in moving from their bed when needed. A systematic review of hospital experiences of people with intellectual disability found similar findings, citing failures of hospitals and staff to meet patient needs due to limited knowledge and skills of staff, negative attitudes, hospital systems failing to make required adjustments, and reliance on carers for both care and advocacy for appropriate treatment.
There is some evidence that tools like AUM improve PWIDD's experiences and outcomes.
Patient-held medication lists may improve experience by (a) creating the "glue" between disjointed healthcare systems, (b) enhancing situational awareness among clinical teams, (c) support clinical teams in checking for errors, (d) ease challenges in communication, (e) improve patient empowerment, (f) serve as a memory aide during appointments when patients are under stress, (g) serve as a reminder to take medications, and (h) serve as a reminder for clinicians to reorder medications.
Among people with diabetes undergoing surgery, those randomized to use of health passports similar to AUM received more information about their expected diabetes care prior to surgery (92% vs 35%), were more involved in planning their diabetes care, were less anxious while in the hospital, more prepared to manage their diabetes care on discharge, and had a shorter mean length of stay (4.4 vs 6.5 days) compared to controls. Among people with diabetes in New Zealand, use of a health passport was associated with a relative reduction in HbA1c of 0.4% (a measure of diabetes control) and a relative increase in weight of 1.0 kg/m2, but no changes in diabetes knowledge, attitudes to diabetes or risk factors for diabetic tissue damage. In another study of adults with diabetes followed in nine Dutch general hospitals, use of a healthcare passport let to small but significant changes in mean HbA1c levels.
There is no published evidence on the impact of health passports on use of restraints during ED visits in any population. Among individuals with congenital heart disease, a health passport showed initial improvements in disease knowledge or physical activity intensity, but those effects were not sustained at 6 months or 1 year. Among individuals with inflammatory bowel disease, health passports and Standardized routine email interactions between an IBD nurse and patients does not reliably improve most traditional disease outcomes. Among individuals with rheumatoid arthritis, there were no effects on self-efficacy expectations, knowledge, health status, or behavior among those with and without health passports.
Because previous studies have shown mixed results of using health passports and other tools similar to AUM, and no prior studies have examined their impact in particular on the use of restraints during ED visits, it is important to systematically collect new data for analysis to determine whether this tool will meaningfully reduce rates of use of restraints during ED visits, and improve the experience of PWIDD, their care partners.
Compelling data and rigorous evaluation findings will allow clinics, hospitals and health systems, insurers, disability service organizations, and public agencies like Medicaid or departments for developmental disabilities to make informed decisions about whether/how to expand use of the tool. Findings from this evaluation will also support stakeholders in developing business cases for covering use of the tool as a benefit, whether in an insurance product or as part of government or community programs.
The investigators will conduct a two-arm, pragmatic randomized controlled trial (RCT) of PWIDD, who will be randomized 1:1 to either to standard care plus AUM, or to the control group that will receive standard care and will not have access to the tool stratified by PWIDD or proxy respondent status and presence of maladaptive behaviors. This is a non-blinded study because the nature of the intervention prevents participants from being blinded to their study arm. The primary goal of this study is to compare the effectiveness of the AUM mobile app vs. standard care on the use of restraints and experience of PWIDD and their care partners in the ED and in other clinical settings.
The study team will recruit potential participants who have engaged with any Northwell Health facility in the previous 12 months. The team's goal is to enroll 1,500 eligible PWIDD. If participants are unable to answer questions on their own, legally authorized representative will be engaged to provide proxy responses. Primary research participants will be asked to identify an individual who assists with medical care (care partner). Care partners will be approached for participation as secondary research subjects and will answer survey questions about their own experience while caring for their PWIDD care recipient in ED and ambulatory settings.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
for primary participant/PWIDD (person with intellectual and/or developmental disability):
The app will allow the user to organize their healthcare information and personal needs which can help improve communication with doctors, clinicians and first responders.
Time frame: 12 months
Measured using electronic medical record data.
Time frame: 12 months
Captured using electronic medical record data.
Time frame: Baseline, 6 months, 12 months
Measured through the Emergency Department Consumer Assessment of Healthcare Providers and Systems (ED CAHPS). The questions were modified for reading level of the respondent and appropriateness for the study. This includes 17-19 questions that require yes/no, Likert Scale, and select-all-that-apply answers.
Time frame: Baseline, 6 months, 12 months
Measured through the Quality of Life In Neurological Disorders Measurement System - stigma short form (Neuro-QoL stigma SF), a validated survey that includes 8 questions with Likert scale answer choices.
Time frame: Baseline, 6 months, 12 months
Measured through Quality of Life In Neurological Disorders Measurement System - communication short form (Neuro-QoL communication SF), a validated survey that includes 5 questions with Likert scale answer choices.
Time frame: Baseline, 6 months, 12 months
Measured through the Patient-Reported Outcomes Measurement Information Systems Global Health (PROMIS global health), a validated survey that includes 10 questions with Likert scale answer choices.
Time frame: baseline, 6 months, 12 months
Measured through the Outcomes for Wellbeing and Distress Scale (OWLS-ID) for people with intellectual disability. This includes 27 that ask about positive well-being, emotional and behavioral discomfort, and anxiety on a Likert scale.
Time frame: baseline, 6 months, 12 months
Measured through the Patient-Health Care Provider Communications Scale (PHCPCS). This includes 21 questions that ask on a Likert scale about positive (17 questions) and negative (4 questions) interactions.
Time frame: Baseline, 6 months, 12 months
Measured by the System Usability Scale (SUS). This is a validated survey with 10 questions that use Likert Scale answer choices. On yes/no question was added to capture perceived usage of the mobile app.
Time frame: Baseline, 6 months, 12 months
Measured through the Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CG CAHPS). The questions were modified to address experiences in the urgent care setting, for reading level of respondent, and appropriateness for the study. This includes 20-22 questions that require yes/no, Likert Scale, and select-all-that-apply answers.
Time frame: Baseline, 6 months, 12 months
Measured through the Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CG CAHPS). The questions were modified to address experiences in the outpatient clinic, for reading level of respondent, and appropriateness for the study. This includes 20-22 questions that require yes/no, Likert Scale, and select-all-that-apply answers.
Time frame: Baseline, 6 months, 12 months
Measured through the Patient-Reported Outcomes Measurement Information Systems Self Efficacy (PROMIS self-efficacy), a validated survey that includes 8 questions with Likert scale answer choices.
Time frame: Baseline, 6 months, 12 months
Measured by the Patient-Reported Outcomes Measurement Information Systems - Sleep-Related Impairment (PROMIS Short Form v1.0 - Sleep-Related Impairment - Short Form 4a), a validated survey that includes 4 questions with Likert Scale answer choices.
Time frame: Baseline, 6 months, 12 months
Measured by the Quality of Life In Neurological Disorders Measurement System - Sleep Disturbance (Neuro-QOL Item Bank v1.0 - Sleep Disturbance - Short Form), a validated survey that includes 8 questions with Likert Scale answer choices.
Time frame: Baseline, 6 months, 12 months
Measured by the Patient-Reported Outcomes Measurement Information Systems - Gastrointestinal Gastroesophageal Reflux (PROMIS® Scale v1.0 - Gastrointestinal Gastroesophageal Reflux 13a), a validated survey that includes 13 questions with Likert Scale answer choices.
Time frame: Baseline, 6 months, 12 months
Measured by the Patient-Reported Outcomes Measurement Information Systems - Gastrointestinal Constipation (PROMIS Scale v1.0 - Gastrointestinal Constipation 9a), a validated survey that includes 9 questions with Likert Scale answer choices.
Time frame: Baseline, 6 months, 12 months
Measured by the Quality of Life In Neurological Disorders Measurement System- Emotional and Behavioral Dyscontrol (Neuro-QOL Item Bank v1.0 - Emotional and Behavioral Dyscontrol - Short Form), a validated survey that includes 8 questions with Likert Scale answer choices.
Time frame: Baseline, 6 months, 12 months
Measured by the Patient-Reported Outcomes Measurement Information Systems - Depression (PROMIS® Item Bank v1.0 - Emotional Distress-Depression - Short Form 4a), a validated survey that includes 4 questions with Likert Scale answer choices.
Time frame: Baseline, 6 months, 12 months
Measured by the Patient-Reported Outcomes Measurement Information Systems - Emotional Distress-Anxiety (PROMIS Item Bank v1.0-Emotional Distress-Anxiety - Short Form 4a), a validated survey that includes 4 questions with Likert Scale answer choices.
Contact information is provided by the study sponsor or research team.
Caren Steinway, LMSW, MPH
CONTACT
Sophia Jan Division Chief, MD, MSHP
CONTACT
Northwell Health
Other
Acronym: SCANS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06857539
Brain Damage, Chronic, Brain Diseases
Cork, Ireland
View Trial DetailsNCT07027891
Acute Coronary Syndrome, Cardiovascular Diseases
Seoul, South Korea
View Trial DetailsNCT07728123
Blood-Borne Infections, Communicable Diseases
Tampa, Florida, United States
View Trial DetailsNCT07185828
Behavior Change Interventions, Disease Attributes
Danville, Pennsylvania, United States
View Trial Details